According to the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) is the third leading cause of ...

A rare cell type in the lungs is essential to survival from the COVID-19 virus, a new study shows.

Onchilles Pharma, a private biotech company pioneering next-generation cytotoxic therapeutics that harness the ELANE pathway, today announced the presentation of new preclinical data for its lead drug ...

Experiments in mice infected with the SARS-CoV-2 virus revealed that the immune cell class in question, called nerve and ...

Scientists have discovered that a rare immune cell type in the lungs, called NAMs, plays a crucial role in surviving COVID-19 ...